Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Progression"" wg kryterium: Temat


Tytuł:
Predicting the molecular mechanism-driven progression of breast cancer through comprehensive network pharmacology and molecular docking approach.
Autorzy:
Vyas B; School of Interdisciplinary Science and Technology, Jamia Hamdard, New Delhi, India.
Kumar S; ICAR-Indian Institute of Farming System Research, Modipuram, Meerut, 250110, India.
Bhowmik R; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.
Akhter M; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Aug 22; Vol. 13 (1), pp. 13729. Date of Electronic Publication: 2023 Aug 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Network Pharmacology*
Breast Neoplasms*/drug therapy
Breast Neoplasms*/metabolism
Molecular Docking Simulation*
Disease Progression*
Humans ; Biomarkers, Tumor ; Haplotypes ; Linkage Disequilibrium ; Endometriosis/drug therapy ; Polymorphism, Single Nucleotide ; Reproducibility of Results ; Drug Repositioning ; United States Food and Drug Administration/legislation & jurisprudence ; United States ; Drug Approval
Czasopismo naukowe
Tytuł:
Stratifying risk for multiple, recurrent, and large (≥3 cm) Ta, G1/G2 tumors in non-muscle-invasive bladder cancer.
Autorzy:
Suh J; Department of Urology, Asan Medical Center, Seoul, Korea.
Jung JH; Seoul Leaders Urology Clinic, Seoul, Korea.
Kwak C; Department of Urology, Seoul National University Hospital, Seoul, Korea.; Department of Urology, Seoul National University College of Medicine, Seoul, Korea.
Kim HH; Department of Urology, Seoul National University Hospital, Seoul, Korea.; Department of Urology, Seoul National University College of Medicine, Seoul, Korea.
Ku JH; Department of Urology, Seoul National University Hospital, Seoul, Korea.; Department of Urology, Seoul National University College of Medicine, Seoul, Korea. .
Pokaż więcej
Źródło:
Investigative and clinical urology [Investig Clin Urol] 2021 Jul; Vol. 62 (4), pp. 408-415.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Disease Progression*
Carcinoma, Transitional Cell/*pathology
Neoplasm Recurrence, Local/*pathology
Neoplasms, Second Primary/*pathology
Urinary Bladder Neoplasms/*pathology
Adjuvants, Immunologic/therapeutic use ; Aged ; BCG Vaccine/therapeutic use ; Carcinoma, Transitional Cell/drug therapy ; Carcinoma, Transitional Cell/surgery ; Chemotherapy, Adjuvant ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Myalgia/pathology ; Neoplasm Staging ; Progression-Free Survival ; Proportional Hazards Models ; Risk Assessment/methods ; Survival Rate ; Tumor Burden ; Urinary Bladder Neoplasms/drug therapy ; Urinary Bladder Neoplasms/surgery
Czasopismo naukowe
Tytuł:
A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients.
Autorzy:
Bedon L; Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano (PN), Italy.; Department of Chemical and Pharmaceutical Sciences, University of Trieste, Via L. Giorgieri 1, 34127 Trieste, Italy.
Dal Bo M; Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano (PN), Italy.
Mossenta M; Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano (PN), Italy.; Department of Life Sciences, University of Trieste, 34127 Trieste, Italy.
Busato D; Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano (PN), Italy.; Department of Life Sciences, University of Trieste, 34127 Trieste, Italy.
Toffoli G; Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano (PN), Italy.
Polano M; Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano (PN), Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Jan 22; Vol. 22 (3). Date of Electronic Publication: 2021 Jan 22.
Typ publikacji:
Journal Article
MeSH Terms:
Disease Progression*
Epigenesis, Genetic*
Carcinoma, Hepatocellular/*genetics
Liver Neoplasms/*genetics
Adult ; Aged ; Algorithms ; Biomarkers, Tumor/metabolism ; CpG Islands ; DNA/genetics ; DNA Methylation ; Decision Making ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Genome-Wide Association Study ; Humans ; Kaplan-Meier Estimate ; Machine Learning ; Male ; Middle Aged ; Prognosis ; Progression-Free Survival ; Proportional Hazards Models ; Regression Analysis ; Risk ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Reasons for Treatment Discontinuation and Their Effect on Outcomes of Immunotherapy in Southwest Finland: A Retrospective, Real-World Cohort Study.
Autorzy:
Virtanen, Saana (AUTHOR)
Pihlman, Heidi (AUTHOR)
Silvoniemi, Maria (AUTHOR)
Vihinen, Pia (AUTHOR)
Jaakkola, Panu (AUTHOR)
Mattila, Kalle E. (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Feb2024, Vol. 16 Issue 4, p709. 11p.
Czasopismo naukowe
Tytuł:
Insights into Disease Progression of Translational Preclinical Rat Model of Interstitial Pulmonary Fibrosis through Endpoint Analysis.
Autorzy:
Kadam AH; Proteogenomics Research Institute for Systems Medicine (PRISM), 505 Coast Blvd. South, La Jolla, CA 92037, USA.
Schnitzer JE; Proteogenomics Research Institute for Systems Medicine (PRISM), 505 Coast Blvd. South, La Jolla, CA 92037, USA.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Mar 15; Vol. 13 (6). Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Procollagen*
Idiopathic Pulmonary Fibrosis*/pathology
Rats ; Humans ; Animals ; Fibrosis ; Collagen/metabolism ; Bleomycin ; Disease Progression
Czasopismo naukowe
Tytuł:
Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer.
Autorzy:
Chiu LC; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Hsu PC; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Wang CC; Division of Pulmonary & Critical Care Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Ko HW; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Kuo SC; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Ju JS; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Tung PH; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Huang AC; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Yang CT; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.; Department of Internal Medicine, Taoyuan Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Department of Respiratory Therapy, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (7), pp. 529-537. Date of Electronic Publication: 2024 Jan 26.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Liver Neoplasms*
Humans ; Afatinib/therapeutic use ; Progression-Free Survival ; Retrospective Studies ; ErbB Receptors/genetics ; Mutation ; Protein Kinase Inhibitors/therapeutic use
Czasopismo naukowe
Tytuł:
Progression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer's disease.
Autorzy:
Jönsson L; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, 171 64, Sweden. .
Ivkovic M; Novo Nordisk A/S, Søborg, Denmark.
Atri A; Banner Sun Health Research Institute and Banner Alzheimer's Institute, Banner Health, Sun City and Phoenix, AZ, USA.; Center for Brain/Mind Medicine, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Handels R; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, 171 64, Sweden.; Faculty of Health, Medicine and Life Sciences, School for Mental Health and Neuroscience, Department of Psychiatry and Neuropsychology, Alzheimer Centre Limburg, Maastricht University Medical Centre+, Maastricht, MD, 6200, The Netherlands.
Gustavsson A; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, 171 64, Sweden.; Quantify Research, Hantverkargatan 8, Stockholm, 112 21, Sweden.
Hahn-Pedersen JH; Novo Nordisk A/S, Søborg, Denmark.
León T; Novo Nordisk A/S, Søborg, Denmark.
Lilja M; Quantify Research, Hantverkargatan 8, Stockholm, 112 21, Sweden.
Gundgaard J; Novo Nordisk A/S, Søborg, Denmark.
Raket LL; Novo Nordisk A/S, Søborg, Denmark.; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Feb 29; Vol. 16 (1), pp. 48. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/diagnostic imaging
Alzheimer Disease*/drug therapy
Cognitive Dysfunction*/diagnostic imaging
Cognitive Dysfunction*/drug therapy
Humans ; Disease Progression ; Mental Status and Dementia Tests ; Research Design ; Clinical Trials as Topic ; Models, Theoretical
Czasopismo naukowe
Tytuł:
Association of blood cadmium concentration with chronic obstructive pulmonary disease progression: a prospective cohort study.
Autorzy:
Sun J; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.; Institute of Respiratory Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.
Deng YP; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.; Institute of Respiratory Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.
Xu J; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.; Institute of Respiratory Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.
Zhu FM; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.; Institute of Respiratory Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.
He QY; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.; Institute of Respiratory Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.
Tang MM; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.; Institute of Respiratory Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.
Liu Y; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.; Institute of Respiratory Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.
Yang J; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.; Institute of Respiratory Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.
Liu HY; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.; Institute of Respiratory Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.; Center for Big Data and Population Health of IHM, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.
Fu L; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China. .; Institute of Respiratory Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China. .; Center for Big Data and Population Health of IHM, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China. .
Zhao H; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China. .; Institute of Respiratory Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China. .; Center for Big Data and Population Health of IHM, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2024 Feb 17; Vol. 25 (1), pp. 91. Date of Electronic Publication: 2024 Feb 17.
Typ publikacji:
Journal Article
MeSH Terms:
Cadmium*
Pulmonary Disease, Chronic Obstructive*/diagnosis
Pulmonary Disease, Chronic Obstructive*/epidemiology
Pulmonary Disease, Chronic Obstructive*/complications
Humans ; Prospective Studies ; Disease Progression ; Hospitalization
Czasopismo naukowe
Tytuł:
Relationships of change in Clinical Dementia Rating (CDR) on patient outcomes and probability of progression: observational analysis.
Autorzy:
Tariot PN; Banner Alzheimer's Institute, Phoenix, AZ, 85006, USA. .
Boada M; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, 08028, Barcelona, Spain.; Networking Research Center On Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Lanctôt KL; Sunnybrook Research Institute, Toronto, ON, M4N 3M5, Canada.
Hahn-Pedersen J; Novo Nordisk A/S, 2860, Søborg, Denmark.
Dabbous F; Evidera, Bethesda, MD, 20814, USA.
Udayachalerm S; Evidera, Bethesda, MD, 20814, USA.
Raket LL; Novo Nordisk A/S, 2860, Søborg, Denmark.; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.
Halchenko Y; Evidera, Bethesda, MD, 20814, USA.
Michalak W; Novo Nordisk A/S, 2860, Søborg, Denmark.
Weidner W; Alzheimer's Disease International, London, SE1 4PU, UK.
Cummings J; Chambers-Grundy Center for Transformative Neuroscience, UNLV, Las Vegas, NV, 89154, USA.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Feb 15; Vol. 16 (1), pp. 36. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/drug therapy
Dementia*/diagnosis
Cognitive Dysfunction*/psychology
Humans ; Aged ; Activities of Daily Living ; Disease Progression ; Mental Status and Dementia Tests ; Probability
Czasopismo naukowe
Tytuł:
The association between fear of progression and medical coping strategies among people living with HIV: a cross-sectional study.
Autorzy:
Li B; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Lin X; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Chen S; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Qian Z; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Wu H; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Liao G; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Chen H; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Kang Z; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Peng J; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. .
Liang G; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. .
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Feb 12; Vol. 24 (1), pp. 440. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Journal Article
MeSH Terms:
Acquired Immunodeficiency Syndrome*
HIV Infections*/epidemiology
Humans ; Cross-Sectional Studies ; Coping Skills ; HIV ; Disease Progression ; Fear/psychology ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Analysis of progression after elective distal ureterectomy and effects of salvage radical nephroureterectomy in patients with distal ureteral urothelial carcinoma.
Autorzy:
Lee CU; Department of Urology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Gyeonggi-do, Republic of Korea.
Lee JH; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Lee HW; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Chung JH; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Song W; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Kang M; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Jeon HG; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Jeong BC; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Seo SI; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Jeon SS; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.
Sung HH; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 12; Vol. 14 (1), pp. 3497. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Journal Article
MeSH Terms:
Ureter*/surgery
Ureter*/pathology
Ureteral Neoplasms*
Carcinoma, Transitional Cell*/pathology
Urinary Bladder Neoplasms*/surgery
Kidney Neoplasms*/pathology
Humans ; Nephroureterectomy ; Nephrectomy ; Disease Progression ; Retrospective Studies ; Neoplasm Recurrence, Local/surgery
Czasopismo naukowe
Tytuł:
Relationship between fear of progression and symptom burden, disease factors and social/family factors in patients with stage-IV breast cancer in Shandong, China.
Autorzy:
Lu Q; Department of Breast Cancer Internal Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Liu Q; Department of Breast Cancer Internal Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Fang S; Department of Breast Cancer Internal Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Ma Y; Department of Breast Cancer Internal Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Zhang B; Department of Breast Cancer Internal Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Li H; Department of Breast Cancer Internal Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Song L; Department of Breast Cancer Internal Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (4), pp. e6749.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Breast Neoplasms*/epidemiology
Breast Neoplasms*/psychology
Humans ; Female ; Symptom Burden ; Quality of Life/psychology ; Fear/psychology ; Surveys and Questionnaires ; China/epidemiology ; Disease Progression
Czasopismo naukowe
Tytuł:
Enhanced clinical outcomes with radiotherapy in diagnostically challenging intracranial plasmacytomas: Analysis of 190 cases.
Autorzy:
Feng Y; Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Zhang Z; Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Qiu F; Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Yang Z; Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Xiong J; Department of Pathology, Huashan Hospital, Fudan University, Shanghai, China.
Zhu W; Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Wan F; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
Chen B; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
Wang J; Division of Life Science, Department of Chemical and Biological Engineering, and State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong SAR, China.; SIAT-HKUST Joint Laboratory of Cell Evolution and Digital Health, HKUST Shenzhen-Hong Kong Collaborative Innovation Research Institute, Shenzhen, China.; Hong Kong Center for Neurodegenerative Diseases, InnoHK, Hong Kong SAR, China.
Zhang Y; Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Hua W; Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai, China.; Neurosurgical Institute of Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (4), pp. e7017.
Typ publikacji:
Journal Article
MeSH Terms:
Plasmacytoma*/diagnostic imaging
Plasmacytoma*/radiotherapy
Multiple Myeloma*/pathology
Bone Neoplasms*/pathology
Humans ; Middle Aged ; Retrospective Studies ; Ki-67 Antigen ; Disease Progression
Czasopismo naukowe
Tytuł:
Traditional Clinicopathological Biomarkers Still Determine Disease-Free and Overall Survival in Invasive Breast Cancer Patients: A Pilot Study.
Autorzy:
Wrzeszcz, Katarzyna (AUTHOR)
Kwiatkowska, Katarzyna (AUTHOR)
Rhone, Piotr (AUTHOR)
Formanowicz, Dorota (AUTHOR)
Kruszewski, Stefan (AUTHOR)
Ruszkowska-Ciastek, Barbara (AUTHOR)
Pokaż więcej
Źródło:
Journal of Clinical Medicine. Apr2024, Vol. 13 Issue 7, p2021. 23p.
Czasopismo naukowe
Tytuł:
Is There a Two-Way Risk between Decreased Testosterone Levels and the Progression and Prognosis of Chronic Kidney Disease? A Cohort Study Based on the National Health and Nutrition Examination Survey Database.
Autorzy:
Jiashan Pan
Zhenming Zheng
Xike Mao
Dekai Hu
Wenbo Wang
Guiyi Liao
Zongyao Hao
Pokaż więcej
Źródło:
World Journal of Men's Health. Apr2024, Vol. 42 Issue 2, p429-440. 12p.
Czasopismo naukowe
Tytuł:
Plasma Epstein-Barr virus microRNA BART8-3p as a potential biomarker for detection and prognostic prediction in early nasopharyngeal carcinoma.
Autorzy:
Lin, Cheng (AUTHOR)
Chen, Yuebing (AUTHOR)
Lin, Xiandong (AUTHOR)
Peng, Hewei (AUTHOR)
Huang, Juan (AUTHOR)
Lin, Shaojun (AUTHOR)
Pan, Jianji (AUTHOR)
Li, Meifang (AUTHOR)
Zong, Jingfeng (AUTHOR)
Pokaż więcej
Źródło:
Scientific Reports. 3/28/2024, Vol. 14, p1-10. 10p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies